Vitamin D supplementations as adjunct to anti-tuberculosis drugs in Mongolia

蒙古将维生素 D 补充剂作为抗结核药物的辅助药物

• 批准号: 8097023
• 负责人: Ganmaa Davaasambuu
• 金额: $ 5.38万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2012-01-01
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8097023
• 关键词: Antitubercular Agents; Award; Back; Body Weight Changes; CD3 Antigens; CD8B1 gene; Cause of Death; Cell Count; Cells; Cessation of life; Child; Clinical; Consent; Developed Countries; Developing Countries; Development; Epidemiology; Evaluation; Goals; Health Benefit; Health Professional; Immune; Immune response; Immunology; Infection; Interleukin-12; Interleukin-17; Interleukin-2; Interleukin-4; Lead; Measures; Mediating; Mentors; Mongolia; Outcome; Patients; Pharmaceutical Preparations; Pharmacotherapy; Pilot Projects; Plasma; Prevention; Production; Public Health; Recruitment Activity; Regimen; Relapse; Schools; Specimen; Sputum; Supplementation; TNF gene; Testing; Tuberculosis; United States; Vitamin D; Vitamin D Deficiency; Work; antimicrobial; cytokine; disorder prevention; follow-up; global health; immune function; improved; in vitro testing; lymphocyte proliferation; macrophage; meetings; monocyte; nutrition; nutritional epidemiology; protective effect; randomized trial; tuberculosis drugs